Ignite Creation Date:
2025-12-24 @ 11:46 PM
Ignite Modification Date:
2025-12-25 @ 9:40 PM
Study NCT ID:
NCT01512251
Status:
COMPLETED
Last Update Posted:
2020-08-17
First Post:
2011-12-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma
Sponsor:
University of California, San Francisco
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2013-12-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-21
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-20
First Submit QC Date:
None
Study First Post Date:
2012-01-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-23
Results First Submit QC Date:
None
Results First Post Date:
2018-05-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-06
Last Update Post Date:
2020-08-17
Last Update Post Date Type:
ACTUAL